@article{19203b2331c64ce08ae20707becb4c00,
title = "Phase I/II study of single agent MCLA-128, a full length IgG1 bispecific antibody targeting the HER3 pathway: Overall safety at the recommended phase II dose (R2PD) and preliminary activity in HER2+ metastatic gastric/gastroesophageal junction cancer (GC/GEJ)",
author = "M. Alsina and A. Varga and A. Amatu and Schellens, \{J. H.M.\} and Witteveen, \{P. O.\} and V. Boni and V. Moreno and K. Bol and A. Lourbakos and \{Magin Ferrer\}, M. and E. Wasserman",
year = "2018",
month = oct,
day = "1",
doi = "10.1093/annonc/mdy282.048",
language = "English",
volume = "29",
pages = "viii223--viii224",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
publisher = "Elsevier Limited",
}